Christopher Maisel
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
-
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
- Hematology 20
- Multiple Myeloma Research and Treatments 17
- Acute Myeloid Leukemia Research 4
- Chronic Myeloid Leukemia Treatments 3
- Oncology 10
- Peptidase Inhibition and Analysis 5
- Cancer Treatment and Pharmacology 4
- Co-authors
- Nizar J. Bahlis (7 shared papers)Estil Vance (3 shared papers)Stanton L. Gerson (1 shared paper)R.B. Berryman (3 shared papers)Xavier Leleu (11 shared papers)Pingfu Fu (1 shared paper)Edward Agura (2 shared papers)Barry Cooper (2 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Blood (5 papers)HemaSphere (3 papers)British Journal of Haematology (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United StatesSpainFrance
In The Last Decade
Christopher Maisel
19 papers receiving 126 citations
Peers
Comparison fields: 5 of 26
- Hematology 89
- Oncology 53
- Genetics 15
- Molecular Biology 79
- Public Health, Environmental and Occupational Health 17
Countries citing papers authored by Christopher Maisel
This map shows the geographic impact of Christopher Maisel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Maisel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Maisel more than expected).
Fields of papers citing papers by Christopher Maisel
This network shows the impact of papers produced by Christopher Maisel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Maisel. The network helps show where Christopher Maisel may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Maisel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 23 | |
| 2 | 2011 | 23 | |
| 3 | 2023 | 21 | |
| 4 | 2018 | 11 | |
| 5 | 2019 | 10 | |
| 6 | 2006 | 9 | |
| 7 | 2021 | 8 | |
| 8 | 2020 | 4 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 3 | |
| 11 | 2007 | 2 | |
| 12 | 2019 | 2 | |
| 13 | 2019 | 2 | |
| 14 | 2023 | 1 | |
| 15 | 2019 | 1 | |
| 16 | 2019 | 1 | |
| 17 | 2021 | 1 | |
| 18 | 2023 | 1 | |
| 19 | 2014 | 1 | |
| 20 | 2023 | 0 |
About Christopher Maisel
Christopher Maisel is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Public Health, Environmental and Occupational Health, having authored 20 papers that have together received 127 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (17 papers), Protein Degradation and Inhibitors (7 papers), Peptidase Inhibition and Analysis (5 papers), Cancer Treatment and Pharmacology (4 papers), Acute Myeloid Leukemia Research (4 papers), Histone Deacetylase Inhibitors Research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Hematology (89 citations), Oncology (53 citations), Genetics (15 citations), Molecular Biology (79 citations) and Public Health, Environmental and Occupational Health (17 citations). Christopher Maisel has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Nizar J. Bahlis, Estil Vance, Stanton L. Gerson, R.B. Berryman, Xavier Leleu, Pingfu Fu, Edward Agura, Barry Cooper, Giovanna Saracino and Lili Liu. Their work appears in journals such as Journal of Clinical Oncology, Blood, HemaSphere, British Journal of Haematology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.